Continous intrathecal baclofen treatment for spasticity in children with cerebral palsy

Continous intrathecal baclofen treatment for spasticity in children with cerebral palsy

Michael Vloebergh MD PhD
Senior Lecturer in Paediatric Neurosurgery
Consultant Paediatric Neurosurgeon
University of Nottingham
Queen's Medical Centre, England

Authors disclaimer: The presentation is based on the literature, personal experience and the continous audit of the patient data at Queens Medical Centre (QMC) Nottingham, England. Some procedures are different than the ones found in the current literature. There are also statements from personal experience of the surgeon, which may not comply with the mainstream reasoning on ITB. The manufacturer of the drug delivery system e.g Medtronic had kindly sponsored the production of this media. Illustrations of the Medtronic products were used with permission. The information is designed for professionals, patients and carers and aims to inform and advise parents and patients about the benefits, the process and the down sides of intrathecal baclofen therapy in children with cerebral palsy